跳至主要内容
临床试验/NCT00542204
NCT00542204已完成不适用

Patient-Centered Online Disease Management Using a Personal Health Record System

Palo Alto Medical Foundation6 个研究点 分布在 1 个国家目标入组 415 人开始时间: 2008年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
415
试验地点
6
主要终点
Hemoglobin A1C

研究概览

简要总结

Diabetes is a major, growing, and costly chronic disease in the U.S., and implementation of recommended diabetes care remains poor, not merely suboptimal, and varied for a sizable proportion of Americans with diabetes. To further reduce the treatment and adherence gaps in diabetes care, the researchers propose to evaluate a Customized, Continuous Care Management (CCCM) program that actively supports a partnership between the patient and his/her multidisciplinary care management (CM) team using an online disease management (ODM) system, which is integrated with a comprehensive electronic health record (EHR) system that includes a personal health record and secure patient-clinician messaging capabilities. The CCCM program builds upon CM strategies proven effective in past studies and creates an ODM system that is built upon and fully integrated with a leading, commercially available EHR product - providing a blueprint for instituting customized, continuous care management for many different chronic conditions in a range of ambulatory care settings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •>= 18 years of age
  • •Have a designated Palo Alto Medical Foundation Primary Care Provider (PCP)
  • •Seen in primary or specialty care at the Palo Alto Division at least once in the preceding 24 months
  • •Diagnosis of diabetes
  • •Baseline A1C >= 7.5%

排除标准

  • •Initial diagnosis of diabetes within the last 12 months
  • •Diagnosis of Type 1 diabetes
  • •Inability to speak and read in English
  • •Lack of regular access to a computer with Internet and email capabilities
  • •Unwilling to perform any self-monitoring at home, including blood glucose and blood pressure%
  • •Pregnant, planning to become pregnant, or lactating
  • •Currently enrolled in a care management program at Palo Alto Medical Foundation or elsewhere
  • •PCP determination that the study is inappropriate or unsafe for the patient
  • •Investigator discretion for clinical safety or protocol adherence reasons

研究组 & 干预措施

Online disease management

Experimental

The PAMFOnline-mediated Personalized Health Care Program, which couples a multidisciplinary diabetes care management team with an EHR-integrated Online Disease Management (ODM) system.

干预措施: Online disease management (Behavioral)

Usual care

No Intervention

Usual medical care. No access to the PHCP electronic system and self-management tools supporting this care management.

结局指标

主要结局

Hemoglobin A1C

时间窗: Baseline, 6 months and 12 months

次要结局

  • Cardiovascular risk (e.g., blood pressure and lipids)(Baseline, 6 months and 12 months)
  • Self-management practices(e.g., medication adherence, home monitoring of glucose and BP, diet, and exercise)(Baseline, 6 months and 12 months)
  • Patient experience and satisfaction (e.g., relevant CAHPS measures)(Baseline and 12 months)
  • Patient psychosocial well-being (e.g., diabetes-related emotional distress)(Baseline, 6 months and 12 months)
  • Processes of care (e.g., frequency of lab testing)(Baseline, 6 months and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul Tang

Vice President

Palo Alto Medical Foundation

研究点 (6)

Loading locations...

相似试验